Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Alcoholism 💬 29 genes, 80 drugs (DrugBank) and 63 diseases |
SLC6A3 [1] SLC6A3 💬Alcoholism
|
Bupropion hydrochloride Bupropion hydrochloride 💬Alcoholism
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬1. Alcoholism
|
||||||||||||||||||||||||||||||||||||||
| 2 | Alcoholism 💬 29 genes, 80 drugs (DrugBank) and 63 diseases |
SLC6A3 [1] SLC6A3 💬Alcoholism
|
Bupropion Bupropion 💬Alcoholism
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬1. Alcoholism
|
||||||||||||||||||||||||||||||||||||||
| 3 | Alcoholism 💬 29 genes, 80 drugs (DrugBank) and 63 diseases |
SLC6A3 [1] SLC6A3 💬Alcoholism
|
Bupropion hydrobromide Bupropion hydrobromide 💬Alcoholism
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬1. Alcoholism
|
||||||||||||||||||||||||||||||||||||||
| 4 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
PTGS2 [1] PTGS2 💬Alzheimer disease
|
Celecoxib Celecoxib 💬Alzheimer disease
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬4. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||
| 5 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
SLC6A3 [1] SLC6A3 💬Amphetamine addiction
|
Bupropion hydrochloride Bupropion hydrochloride 💬Amphetamine addiction
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬5. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||
| 6 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
SLC6A3 [1] SLC6A3 💬Amphetamine addiction
|
Bupropion Bupropion 💬Amphetamine addiction
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬5. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||
| 7 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
SLC6A3 [1] SLC6A3 💬Amphetamine addiction
|
Bupropion hydrobromide Bupropion hydrobromide 💬Amphetamine addiction
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬5. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||
| 8 | Arachidonic acid metabolism 💬 5 genes, 29 drugs (DrugBank) and 46 diseases |
PTGS2 [1] PTGS2 💬Arachidonic acid metabolism
|
Celecoxib Celecoxib 💬Arachidonic acid metabolism
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬8. Arachidonic acid metabolism
|
||||||||||||||||||||||||||||||||||||||
| 9 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
PTGS2 [1] PTGS2 💬C-type lectin receptor signaling pathway
|
Celecoxib Celecoxib 💬C-type lectin receptor signaling pathway
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬9. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||
| 10 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬cGMP-PKG signaling pathway
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬10. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||
| 11 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬cGMP-PKG signaling pathway
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬10. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||
| 12 | Chemical carcinogenesis - DNA adducts 💬 1 gene, 26 drugs (DrugBank) and 43 diseases |
PTGS2 [1] PTGS2 💬Chemical carcinogenesis - DNA adducts
|
Celecoxib Celecoxib 💬Chemical carcinogenesis - DNA adducts
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬12. Chemical carcinogenesis - DNA adducts
|
||||||||||||||||||||||||||||||||||||||
| 13 | Cocaine addiction 💬 15 genes, 67 drugs (DrugBank) and 58 diseases |
SLC6A3 [1] SLC6A3 💬Cocaine addiction
|
Bupropion hydrochloride Bupropion hydrochloride 💬Cocaine addiction
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬13. Cocaine addiction
|
||||||||||||||||||||||||||||||||||||||
| 14 | Cocaine addiction 💬 15 genes, 67 drugs (DrugBank) and 58 diseases |
SLC6A3 [1] SLC6A3 💬Cocaine addiction
|
Bupropion Bupropion 💬Cocaine addiction
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬13. Cocaine addiction
|
||||||||||||||||||||||||||||||||||||||
| 15 | Cocaine addiction 💬 15 genes, 67 drugs (DrugBank) and 58 diseases |
SLC6A3 [1] SLC6A3 💬Cocaine addiction
|
Bupropion hydrobromide Bupropion hydrobromide 💬Cocaine addiction
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬13. Cocaine addiction
|
||||||||||||||||||||||||||||||||||||||
| 16 | Dopaminergic synapse 💬 33 genes, 105 drugs (DrugBank) and 105 diseases |
SLC6A3 [1] SLC6A3 💬Dopaminergic synapse
|
Bupropion hydrochloride Bupropion hydrochloride 💬Dopaminergic synapse
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬16. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||
| 17 | Dopaminergic synapse 💬 33 genes, 105 drugs (DrugBank) and 105 diseases |
SLC6A3 [1] SLC6A3 💬Dopaminergic synapse
|
Bupropion Bupropion 💬Dopaminergic synapse
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬16. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||
| 18 | Dopaminergic synapse 💬 33 genes, 105 drugs (DrugBank) and 105 diseases |
SLC6A3 [1] SLC6A3 💬Dopaminergic synapse
|
Bupropion hydrobromide Bupropion hydrobromide 💬Dopaminergic synapse
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬16. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||
| 19 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
PTGS2 [1] PTGS2 💬Efferocytosis
|
Celecoxib Celecoxib 💬Efferocytosis
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬19. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||
| 20 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Hormone signaling
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬20. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||
| 21 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Hormone signaling
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬20. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||
| 22 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
PTGS2 [1] PTGS2 💬Human cytomegalovirus infection
|
Celecoxib Celecoxib 💬Human cytomegalovirus infection
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬22. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||
| 23 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
PTGS2 [1] PTGS2 💬Human papillomavirus infection
|
Celecoxib Celecoxib 💬Human papillomavirus infection
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬23. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||
| 24 | IL-17 signaling pathway 💬 20 genes, 65 drugs (DrugBank) and 91 diseases |
PTGS2 [1] PTGS2 💬IL-17 signaling pathway
|
Celecoxib Celecoxib 💬IL-17 signaling pathway
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬24. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||
| 25 | Insulin secretion 💬 16 genes, 51 drugs (DrugBank) and 61 diseases |
SNAP25 [1] SNAP25 💬Insulin secretion
|
Botulinum toxin type A Botulinum toxin type A 💬Insulin secretion
| Botulinum toxin type A | 002 [13] 2 , 5 , 6 , 7 , 13, 15, 17, 47, 70, 113, 149, 171, 226 💬25. Insulin secretion
|
||||||||||||||||||||||||||||||||||||||
| 26 | Insulin secretion 💬 16 genes, 51 drugs (DrugBank) and 61 diseases |
SNAP25 [1] SNAP25 💬Insulin secretion
|
Incobotulinumtoxin A Incobotulinumtoxin A 💬Insulin secretion
| Botulinum toxin type A | 002 [13] 2 , 5 , 6 , 7 , 13, 15, 17, 47, 70, 113, 149, 171, 226 💬25. Insulin secretion
|
||||||||||||||||||||||||||||||||||||||
| 27 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
PTGS2 [1] PTGS2 💬Kaposi sarcoma-associated herpesvirus infection
|
Celecoxib Celecoxib 💬Kaposi sarcoma-associated herpesvirus infection
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬27. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||
| 28 | Leishmaniasis 💬 40 genes, 76 drugs (DrugBank) and 105 diseases |
PTGS2 [1] PTGS2 💬Leishmaniasis
|
Celecoxib Celecoxib 💬Leishmaniasis
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬28. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||
| 29 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
PTGS2 [1] PTGS2 💬MicroRNAs in cancer
|
Celecoxib Celecoxib 💬MicroRNAs in cancer
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬29. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||
| 30 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Neuroactive ligand signaling
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬30. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||
| 31 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Neuroactive ligand signaling
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬30. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||
| 32 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
SLC6A2 [2] SLC6A2, SLC6A3 💬
|
Bupropion hydrochloride Bupropion hydrochloride 💬Neuroactive ligand signaling
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬32. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||
| 33 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
SLC6A2 [2] SLC6A2, SLC6A3 💬
|
Bupropion Bupropion 💬Neuroactive ligand signaling
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬32. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||
| 34 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
SLC6A2 [2] SLC6A2, SLC6A3 💬
|
Bupropion hydrobromide Bupropion hydrobromide 💬Neuroactive ligand signaling
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬32. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||
| 35 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Neuroactive ligand-receptor interaction
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬35. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||
| 36 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Neuroactive ligand-receptor interaction
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬35. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||
| 37 | NF-kappa B signaling pathway 💬 23 genes, 81 drugs (DrugBank) and 97 diseases |
PTGS2 [1] PTGS2 💬NF-kappa B signaling pathway
|
Celecoxib Celecoxib 💬NF-kappa B signaling pathway
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬37. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||
| 38 | Ovarian steroidogenesis 💬 7 genes, 40 drugs (DrugBank) and 53 diseases |
PTGS2 [1] PTGS2 💬Ovarian steroidogenesis
|
Celecoxib Celecoxib 💬Ovarian steroidogenesis
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬38. Ovarian steroidogenesis
|
||||||||||||||||||||||||||||||||||||||
| 39 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
PTGS2 [1] PTGS2 💬Oxytocin signaling pathway
|
Celecoxib Celecoxib 💬Oxytocin signaling pathway
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬39. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||
| 40 | Parkinson disease 💬 24 genes, 73 drugs (DrugBank) and 71 diseases |
SLC6A3 [1] SLC6A3 💬Parkinson disease
|
Bupropion hydrochloride Bupropion hydrochloride 💬Parkinson disease
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬40. Parkinson disease
|
||||||||||||||||||||||||||||||||||||||
| 41 | Parkinson disease 💬 24 genes, 73 drugs (DrugBank) and 71 diseases |
SLC6A3 [1] SLC6A3 💬Parkinson disease
|
Bupropion Bupropion 💬Parkinson disease
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬40. Parkinson disease
|
||||||||||||||||||||||||||||||||||||||
| 42 | Parkinson disease 💬 24 genes, 73 drugs (DrugBank) and 71 diseases |
SLC6A3 [1] SLC6A3 💬Parkinson disease
|
Bupropion hydrobromide Bupropion hydrobromide 💬Parkinson disease
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬40. Parkinson disease
|
||||||||||||||||||||||||||||||||||||||
| 43 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PTGS2 [1] PTGS2 💬Pathways in cancer
|
Celecoxib Celecoxib 💬Pathways in cancer
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬43. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||
| 44 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
PTGS2 [1] PTGS2 💬Pathways of neurodegeneration - multiple diseases
|
Celecoxib Celecoxib 💬Pathways of neurodegeneration - multiple diseases
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬44. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||
| 45 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
SLC6A3 [1] SLC6A3 💬Pathways of neurodegeneration - multiple diseases
|
Bupropion hydrochloride Bupropion hydrochloride 💬Pathways of neurodegeneration - multiple diseases
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬45. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||
| 46 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
SLC6A3 [1] SLC6A3 💬Pathways of neurodegeneration - multiple diseases
|
Bupropion Bupropion 💬Pathways of neurodegeneration - multiple diseases
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬45. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||
| 47 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
SLC6A3 [1] SLC6A3 💬Pathways of neurodegeneration - multiple diseases
|
Bupropion hydrobromide Bupropion hydrobromide 💬Pathways of neurodegeneration - multiple diseases
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬45. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||
| 48 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
PTGS2 [1] PTGS2 💬Regulation of lipolysis in adipocytes
|
Celecoxib Celecoxib 💬Regulation of lipolysis in adipocytes
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬48. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||
| 49 | Retrograde endocannabinoid signaling 💬 34 genes, 70 drugs (DrugBank) and 74 diseases |
PTGS2 [1] PTGS2 💬Retrograde endocannabinoid signaling
|
Celecoxib Celecoxib 💬Retrograde endocannabinoid signaling
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬49. Retrograde endocannabinoid signaling
|
||||||||||||||||||||||||||||||||||||||
| 50 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
PTGS2 [1] PTGS2 💬Serotonergic synapse
|
Celecoxib Celecoxib 💬Serotonergic synapse
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬50. Serotonergic synapse
|
||||||||||||||||||||||||||||||||||||||
| 51 | Small cell lung cancer 💬 15 genes, 47 drugs (DrugBank) and 63 diseases |
PTGS2 [1] PTGS2 💬Small cell lung cancer
|
Celecoxib Celecoxib 💬Small cell lung cancer
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬51. Small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||
| 52 | Synaptic vesicle cycle 💬 8 genes, 32 drugs (DrugBank) and 43 diseases |
SLC6A2 [2] SLC6A2, SLC6A3 💬
|
Bupropion hydrochloride Bupropion hydrochloride 💬Synaptic vesicle cycle
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬52. Synaptic vesicle cycle
|
||||||||||||||||||||||||||||||||||||||
| 53 | Synaptic vesicle cycle 💬 8 genes, 32 drugs (DrugBank) and 43 diseases |
SLC6A2 [2] SLC6A2, SLC6A3 💬
|
Bupropion Bupropion 💬Synaptic vesicle cycle
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬52. Synaptic vesicle cycle
|
||||||||||||||||||||||||||||||||||||||
| 54 | Synaptic vesicle cycle 💬 8 genes, 32 drugs (DrugBank) and 43 diseases |
SLC6A2 [2] SLC6A2, SLC6A3 💬
|
Bupropion hydrobromide Bupropion hydrobromide 💬Synaptic vesicle cycle
| Bupropion | 008 [7] 8 , 18, 21, 96, 97, 171, 298 💬52. Synaptic vesicle cycle
|
||||||||||||||||||||||||||||||||||||||
| 55 | Synaptic vesicle cycle 💬 8 genes, 32 drugs (DrugBank) and 43 diseases |
SNAP25 [1] SNAP25 💬Synaptic vesicle cycle
|
Botulinum toxin type A Botulinum toxin type A 💬Synaptic vesicle cycle
| Botulinum toxin type A | 002 [13] 2 , 5 , 6 , 7 , 13, 15, 17, 47, 70, 113, 149, 171, 226 💬55. Synaptic vesicle cycle
|
||||||||||||||||||||||||||||||||||||||
| 56 | Synaptic vesicle cycle 💬 8 genes, 32 drugs (DrugBank) and 43 diseases |
SNAP25 [1] SNAP25 💬Synaptic vesicle cycle
|
Incobotulinumtoxin A Incobotulinumtoxin A 💬Synaptic vesicle cycle
| Botulinum toxin type A | 002 [13] 2 , 5 , 6 , 7 , 13, 15, 17, 47, 70, 113, 149, 171, 226 💬55. Synaptic vesicle cycle
|
||||||||||||||||||||||||||||||||||||||
| 57 | TNF signaling pathway 💬 25 genes, 64 drugs (DrugBank) and 95 diseases |
PTGS2 [1] PTGS2 💬TNF signaling pathway
|
Celecoxib Celecoxib 💬TNF signaling pathway
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬57. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||
| 58 | VEGF signaling pathway 💬 22 genes, 58 drugs (DrugBank) and 94 diseases |
PTGS2 [1] PTGS2 💬VEGF signaling pathway
|
Celecoxib Celecoxib 💬VEGF signaling pathway
| Celecoxib | 002 [14] 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬58. VEGF signaling pathway
|
Alcoholism
29 genes, 80 drugs (DrugBank) and 63 diseases
Alzheimer disease
59 genes, 136 drugs (DrugBank) and 139 diseases
Amphetamine addiction
25 genes, 58 drugs (DrugBank) and 92 diseases
Arachidonic acid metabolism
5 genes, 29 drugs (DrugBank) and 46 diseases
C-type lectin receptor signaling pathway
28 genes, 71 drugs (DrugBank) and 108 diseases
cGMP-PKG signaling pathway
48 genes, 132 drugs (DrugBank) and 123 diseases
Chemical carcinogenesis - DNA adducts
1 gene, 26 drugs (DrugBank) and 43 diseases
Cocaine addiction
15 genes, 67 drugs (DrugBank) and 58 diseases
Dopaminergic synapse
33 genes, 105 drugs (DrugBank) and 105 diseases
Efferocytosis
30 genes, 78 drugs (DrugBank) and 97 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Human cytomegalovirus infection
65 genes, 121 drugs (DrugBank) and 136 diseases
Human papillomavirus infection
52 genes, 114 drugs (DrugBank) and 121 diseases
IL-17 signaling pathway
20 genes, 65 drugs (DrugBank) and 91 diseases
Insulin secretion
16 genes, 51 drugs (DrugBank) and 61 diseases
Kaposi sarcoma-associated herpesvirus infection
61 genes, 102 drugs (DrugBank) and 124 diseases
Leishmaniasis
40 genes, 76 drugs (DrugBank) and 105 diseases
MicroRNAs in cancer
32 genes, 78 drugs (DrugBank) and 96 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 118 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
NF-kappa B signaling pathway
23 genes, 81 drugs (DrugBank) and 97 diseases
Ovarian steroidogenesis
7 genes, 40 drugs (DrugBank) and 53 diseases
Oxytocin signaling pathway
34 genes, 85 drugs (DrugBank) and 112 diseases
Parkinson disease
24 genes, 73 drugs (DrugBank) and 71 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
Pathways of neurodegeneration - multiple diseases
64 genes, 143 drugs (DrugBank) and 141 diseases
Regulation of lipolysis in adipocytes
13 genes, 72 drugs (DrugBank) and 80 diseases
Retrograde endocannabinoid signaling
34 genes, 70 drugs (DrugBank) and 74 diseases
Serotonergic synapse
40 genes, 130 drugs (DrugBank) and 89 diseases
Small cell lung cancer
15 genes, 47 drugs (DrugBank) and 63 diseases
Synaptic vesicle cycle
8 genes, 32 drugs (DrugBank) and 43 diseases
TNF signaling pathway
25 genes, 64 drugs (DrugBank) and 95 diseases
VEGF signaling pathway
22 genes, 58 drugs (DrugBank) and 94 diseases
